Alibaba Health Information Technology (HK:0241) has released an update.
Alibaba Health Information Technology Limited reported a robust financial performance for the six months ending September 30, 2024, with a notable 10.2% increase in revenue to RMB14.27 billion and a 72.8% surge in net profit. The company saw significant growth in its Taobao and Tmall Healthcare Platform, serving over 300 million consumers and enhancing its pharmaceutical e-commerce platform revenue by 67.5%. Despite a dip in healthcare and digital services revenue, Alibaba Health expanded its direct sales business and continued to innovate in drug tracking and online healthcare services.
For further insights into HK:0241 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- 3 Penny Stocks to Watch Now, 11/24/24
- Palantir Stock Keeps Hitting New 52-Week Highs. Is it Still a Buy?
- Meta Stock Updates: Threads to Showcase Ads, Antitrust Trial on Insta and WhatsApp
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
